Hot Features
プレミアム
Incyte Corporation (INCY)
NASDAQ
登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
| 日付 | 保有者名 | 取引株数 | 金額レンジ ($) | 取引種別 | 価格レンジ ($) | 届出終了時の株数 | % 変化 |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Dr. Pablo J. CagnoniPresident and Global Head of R&D | -25.47k | 2.43M | Sale to Issuer | 95.59 | 27.77k | -47.84% |
| 2026-05-26 | Mr. Thomas TrayPrincipal Financial Officer, VP of Finance & CAO | -2.05k | 199.66k | 売り | 97.35 | 5.97k | -25.58% |
| 2026-05-26 | Mr. Jean-Jacques BienaimeIndependent Director | -13.06k | 164.15k | Derivative Exercise and Sale | 84.53 - 97.10 | 20.26k | - |
| 2026-05-26 | Mr. Jean-Jacques BienaimeIndependent Director | 1.94k | 164.07k | Derivative Exercise and Retained Stock | 84.53 | 20.26k | 10.59% |
| 2026-05-19 | Mr. Paul J. ClancyIndependent Director | -15.00k | 156.00k | Derivative Exercise and Sale | 84.53 - 94.93 | 21.22k | - |
| 2026-05-08 | Baker Bros. Advisors LP法人 | 30.00k | 2.54M | Derivative Exercise and Retained Stock | 84.53 | 31.07M | 0.10% |
| 2026-04-17 | Dr. Pablo J. CagnoniPresident and Global Head of R&D | -18.67k | 505.32k | Derivative Exercise and Sale | 64.25 - 96.50 | 5.14k | - |
| 2026-03-25 | Mr. Matteo Trottaインサイダー | -537.00 | 49.53k | Sale to Issuer | 92.23 | 3.72k | -12.61% |
| 2026-03-17 | Dr. Pablo J. CagnoniPresident and Global Head of R&D | -18.67k | 581.82k | Derivative Exercise and Sale | 61.18 - 94.24 | 5.14k | - |
| 2026-02-19 | Dr. Pablo J. CagnoniPresident and Global Head of R&D | -18.67k | 734.09k | Derivative Exercise and Sale | 61.18 - 100.91 | 5.14k | - |
| 2026-02-02 | Mr. Lee J. HeesonExec. VP & Head of Incyte International | -111.00 | 11.40k | Sale to Issuer | 102.67 | - | - |
| 2026-02-02 | Mr. Michael James MorrisseyExec. VP & Head of Global Technical Operations | -185.00 | 18.99k | Sale to Issuer | 102.67 | 11.51k | -1.58% |
| 2026-01-20 | Mr. Michael James MorrisseyExec. VP & Head of Global Technical Operations | -429.00 | 44.02k | Sale to Issuer | 102.62 | 9.05k | -4.52% |
| 2026-01-07 | Mr. Mohamed Khairie IssaExec. VP & Head of U.S. Commercial | -10.86k | 1.18M | 売り | 109.07 | - | - |
| 2026-01-06 | Mr. Mohamed Khairie IssaExec. VP & Head of U.S. Commercial | -8.26k | 881.44k | Sale to Issuer | 106.66 | - | - |
| 2026-01-05 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -15.63k | 1.59M | 売り | 101.70 | 0.00 | -100.00% |
| 2025-12-31 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -13.29k | 1.31M | Sale to Issuer | 98.77 | 15.63k | -45.95% |
| 2025-12-31 | Mr. Michael James MorrisseyExec. VP & Head of Global Technical Operations | -254.00 | 25.09k | Sale to Issuer | 98.77 | 3.36k | -7.03% |
| 2025-12-19 | Mr. Thomas TrayPrincipal Financial Officer, VP of Finance & CAO | -2.77k | 11.76k | Derivative Exercise and Sale | 95.76 - 100.00 | 7.81k | - |
| 2025-12-18 | Mr. Thomas TrayPrincipal Financial Officer, VP of Finance & CAO | -600.00 | 58.95k | 売り | 98.25 | 7.81k | -7.14% |
| 2025-12-16 | Mr. Michael James MorrisseyExec. VP & Head of Global Technical Operations | -58.33k | 5.68M | 売り | 97.26 - 97.42 | 0.00 | -100.00% |
| 2025-12-10 | Dr. Patrick MayesVP of Biotherapeutic Research | -5.81k | 554.97k | 売り | 94.94 - 95.58 | 153.00 | -97.43% |
| 2025-12-08 | Mr. Herve Hoppenotインサイダー | -2.84k | 274.92k | Sale to Issuer | 96.70 | 256.16k | -1.10% |
| 2025-12-01 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -22.66k | 2.32M | 売り | 102.51 - 102.96 | 0.00 | -100.00% |
| 2025-12-01 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -17.09k | 1.74M | Sale to Issuer | 102.04 | 0.00 | -100.00% |
| 2025-12-01 | Mr. Michael James MorrisseyExec. VP & Head of Global Technical Operations | -326.00 | 33.27k | Sale to Issuer | 102.04 | 58.33k | -0.56% |
| 2025-11-21 | Mr. Thomas TrayPrincipal Financial Officer, VP of Finance & CAO | -769.00 | 79.04k | 売り | 102.00 - 103.00 | 8.41k | -8.38% |
| 2025-11-17 | Ms. Sheila A. Dentonインサイダー | -278.00 | 11.15k | Derivative Exercise and Sale | 64.25 - 104.36 | 656.00 | - |
| 2025-11-10 | Mr. Herve Hoppenotインサイダー | -187.50k | 19.77M | 売り | 105.46 | 256.16k | -42.26% |
| 2025-11-05 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -5.23k | 47.94k | Derivative Exercise and Sale | 83.83 - 102.20 | 2.56k | - |
| 2025-11-04 | Ms. Sheila A. Dentonインサイダー | -598.00 | 25.89k | Derivative Exercise and Sale | 58.06 - 101.36 | 656.00 | - |
| 2025-11-03 | Mr. Lee J. HeesonExec. VP & Head of Incyte International | -3.07k | 289.02k | 売り | 94.02 | - | - |
| 2025-10-15 | Ms. Sheila A. Dentonインサイダー | -277.00 | 5.78k | Derivative Exercise and Sale | 64.25 - 85.13 | 656.00 | - |
| 2025-10-02 | Ms. Sheila A. Dentonインサイダー | -599.00 | 17.72k | Derivative Exercise and Sale | 58.06 - 87.65 | 656.00 | - |
| 2025-10-03 | Ms. Sheila A. Dentonインサイダー | -3.50k | 299.48k | 売り | 85.54 | 656.00 | -84.22% |
| 2025-10-02 | Ms. Sheila A. Dentonインサイダー | -3.13k | 270.06k | Sale to Issuer | 86.28 | 656.00 | -82.67% |
| 2025-10-01 | Dr. Patrick MayesVP of Biotherapeutic Research | -1.57k | 136.03k | Sale to Issuer | 86.70 | 5.96k | -20.84% |
| 2025-10-01 | Mr. Lee J. HeesonExec. VP & Head of Incyte International | -463.00 | 40.14k | Sale to Issuer | 86.70 | - | - |
| 2025-09-16 | Ms. Sheila A. Dentonインサイダー | -278.00 | 5.25k | Derivative Exercise and Sale | 64.25 - 83.15 | 657.00 | - |
| 2025-09-02 | Ms. Sheila A. Dentonインサイダー | -598.00 | 16.09k | Derivative Exercise and Sale | 58.06 - 84.97 | 656.00 | - |
| 2025-08-15 | Ms. Sheila A. Dentonインサイダー | -277.00 | 6.25k | Derivative Exercise and Sale | 64.25 - 86.81 | 657.00 | - |
| 2025-08-04 | Ms. Sheila A. Dentonインサイダー | -598.00 | 10.59k | Derivative Exercise and Sale | 58.06 - 75.77 | 656.00 | - |
| 2025-07-21 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -3.71k | 251.79k | 売り | 67.94 | 2.56k | -59.15% |
| 2025-07-16 | Dr. Barry P. Flannellyインサイダー | -1.34k | 91.60k | 売り | 68.36 | 13.00 | -99.04% |
| 2025-07-16 | Dr. Vijay K. Iyengarインサイダー | -983.00 | 67.20k | 売り | 68.36 | 2.79k | -26.07% |
| 2025-07-15 | Ms. Sheila A. Dentonインサイダー | -3.33k | 18.68k | Derivative Exercise and Sale | 64.25 - 69.86 | 656.00 | - |
| 2025-07-16 | Ms. Sheila A. Dentonインサイダー | -785.00 | 53.66k | 売り | 68.36 | 656.00 | -54.48% |
| 2025-07-15 | Ms. Sheila A. Dentonインサイダー | -703.00 | 47.98k | Sale to Issuer | 68.25 | 656.00 | -51.73% |
| 2025-07-15 | Mr. Matteo Trottaインサイダー | -182.00 | 12.42k | Sale to Issuer | 68.25 | 1.90k | -8.75% |
| 2025-07-14 | Dr. Pablo J. CagnoniPresident and Global Head of R&D | -3.91k | 268.94k | Sale to Issuer | 68.25 - 69.98 | 5.14k | -43.20% |
| 2025-07-14 | Ms. Paula J. Swainインサイダー | -1.01k | 69.50k | Sale to Issuer | 68.25 - 69.98 | 69.09k | -1.44% |
| 2025-07-14 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -14.95k | 1.02M | 売り | 68.47 | 6.27k | -70.47% |
| 2025-07-14 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -3.15k | 217.75k | Sale to Issuer | 68.25 - 69.98 | 6.27k | -33.46% |
| 2025-07-14 | Ms. Christiana Stamoulisインサイダー | -2.85k | 197.08k | Sale to Issuer | 68.25 - 69.98 | 61.75k | -4.41% |
| 2025-07-15 | Dr. Vijay K. Iyengarインサイダー | -1.18k | 82.23k | 売り | 69.86 | 3.77k | -23.79% |
| 2025-07-14 | Dr. Vijay K. Iyengarインサイダー | -1.43k | 98.70k | Sale to Issuer | 68.25 - 69.98 | 3.77k | -27.51% |
| 2025-07-14 | Mr. Thomas TrayPrincipal Financial Officer, VP of Finance & CAO | -1.28k | 88.22k | Sale to Issuer | 68.25 - 69.98 | 9.15k | -12.23% |
| 2025-07-15 | Dr. Barry P. Flannellyインサイダー | -1.19k | 83.27k | 売り | 69.86 | 1.35k | -46.84% |
| 2025-07-14 | Dr. Barry P. Flannellyインサイダー | -2.06k | 142.39k | Sale to Issuer | 68.25 - 69.98 | 1.35k | -60.39% |
| 2025-07-14 | Mr. Herve Hoppenotインサイダー | -9.67k | 668.83k | Sale to Issuer | 68.25 - 69.98 | 443.66k | -2.13% |
| 2025-07-02 | Ms. Paula J. Swainインサイダー | -6.29k | 428.45k | Sale to Issuer | 68.17 | 66.73k | -8.61% |
| 2025-07-02 | Mr. Thomas TrayPrincipal Financial Officer, VP of Finance & CAO | -897.00 | 61.15k | Sale to Issuer | 68.17 | 7.65k | -10.49% |
| 2025-07-02 | Dr. Steven H. SteinExec. VP, Head of Late-stage Development & Chief Medical Officer | -12.71k | 866.71k | Sale to Issuer | 68.17 | 17.51k | -42.06% |
| 2025-07-02 | Ms. Christiana Stamoulisインサイダー | -11.59k | 790.02k | Sale to Issuer | 68.17 | 58.40k | -16.56% |
| 2025-07-03 | Dr. Barry P. Flannellyインサイダー | -10.90k | 743.04k | 売り | 68.15 | 13.00 | -99.88% |
| 2025-07-02 | Dr. Barry P. Flannellyインサイダー | -9.06k | 617.28k | Sale to Issuer | 68.17 | 13.00 | -99.86% |
| 2025-07-02 | Ms. Sheila A. Dentonインサイダー | -599.00 | 6.32k | Derivative Exercise and Sale | 58.06 - 68.61 | 656.00 | - |
| 2025-07-03 | Dr. Vijay K. Iyengarインサイダー | -8.62k | 587.28k | 売り | 68.15 - 68.16 | 2.79k | -75.55% |
| 2025-07-02 | Dr. Vijay K. Iyengarインサイダー | -6.81k | 464.17k | Sale to Issuer | 68.17 | 2.79k | -70.95% |
| 2025-07-02 | Mr. Herve Hoppenotインサイダー | -42.77k | 2.92M | Sale to Issuer | 68.17 | 432.28k | -9.00% |
| 2025-06-10 | Dr. Susanne Schaffertインサイダー | -849.00 | 59.49k | Sale to Issuer | 70.07 | 4.87k | -14.84% |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
メールアドレスで登録
すでにアカウントをお持ちですか？ サインイン
アカウントをお持ちでないですか？ 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。
